Office of Research & Development |
|
Project Number: | I01BX004522-05A1 |
Title: | Novel Therapeutic Strategies for ELQ-422, a preclinical Toxoplasmosis Drug Candidate |
Principal Investigator: | Joseph S Doggett |
Location: | Portland, OR |
Congressional District Code: | 1 |
Research Service: | Biomedical Laboratory R&D |
Project Period: | October 2023 - September 2027 |
FY 2024 Funding Amount: | $215,000 |
Abstract: |
View abstract and other project information on NIH RePORTER Go To NIH RePORTER |